Resources

Low blood sugar, or hypoglycemia, poses a serious health threat for patients with chronic kidney disease (CKD), according to a new study. The findings indicate that hypoglycemia may account for some portion of the excess heart-related deaths seen in CKD patients.

A consensus statement of the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) issues clinical recommendations on the proper treatment of hospitalized patients with high blood glucose levels….

Drinking up to half a glass of wine daily may increase longevity by 5 years in men. Light to moderate alcohol intake also lowers the risk of cardiovascular mortality.

Dangerous hypoglycemic episodes are a significant risk for patients with chronic kidney disease, whether they have diabetes or not, researchers said.

As a food labeling system, a color-coded “traffic light” system is superior to currently used percentage daily intake systems in helping consumers identify healthy foods, according to a new study.

Pharmacists show why they need to be part of the “Diabetes Team” and the Ten City Challenge diabetes education program shows that they can also reduce costs ($1,079/patient) as well as reducing A1c levels along with cholesterol and blood pressure.

Children are eating themselves into an early grave with hundreds of thousands of primary school pupils already suffering from chronic disease, a study has found.

Approximately 6.3 million adults – or one-fourth of the people in the U.S. with diabetes mellitus – are unaware they have the disease, and this undiagnosed population accounts for an estimated $18 billion in health care costs each year.

Patients with extreme obesity achieved 8.3% weight loss after 2 years of intensive medical intervention compared with 0.5% in a control group, according to new research

ROADMAP is the first-ever, large-scale clinical trial, being conducted in 19 European countries to evaluate whether the angiotensin II receptor blocker (ARB) olmesartan medoxomil can prevent the onset of microalbuminuria in patients with Type 2 diabetes (T2DM).